Desgeorges M, Rodier M, Piot M, Demaille J, Claustres M
Laboratoire de Biochimie Génétique, CNRS UPR-9008, Bd Henri IV, Montpellier, France.
Hum Genet. 1995 Dec;96(6):717-20. doi: 10.1007/BF00210305.
We report molecular and clinical analyses in four unrelated patients with cystic fibrosis (CF) with compound heterozygosity for the L206W mutation in the cystic fibrosis transmembrane conductance regulator gene (CFTR). This uncommon missense mutation (frequency less than 1% in a sample of 336 CF chromosomes from Southern France) replaces a leucine by a tryptophan residue in the middle of the third transmembrane domain of CFTR. On the basis of the clinical features presented by the four patients, we postulate that the L206W might be associated with pancreatic sufficiency and residual transmembrane transport of chloride in lung.
我们报告了对四名患有囊性纤维化(CF)的非亲缘患者的分子和临床分析,这些患者在囊性纤维化跨膜传导调节因子基因(CFTR)中存在L206W突变的复合杂合性。这种罕见的错义突变(在来自法国南部的336条CF染色体样本中的频率低于1%)在CFTR的第三个跨膜结构域中部将一个亮氨酸替换为色氨酸残基。根据这四名患者呈现的临床特征,我们推测L206W可能与胰腺功能正常以及肺中氯离子的残余跨膜转运有关。